Sinopharm Group Co. Ltd. (FRA:X2S)

Market Cap	6.32B
Revenue (ttm)	77.35B
Net Income (ttm)	932.89M
Shares Out	n/a
EPS (ttm)	0.30
PE Ratio	6.77
Forward PE	n/a
Dividend	0.11 (5.84%)
Ex-Dividend Date	Jun 16, 2025

Volume	700
Average Volume	2,379
Open	1.984
Previous Close	1.981
Day's Range	1.959 - 1.984
52-Week Range	1.843 - 2.717
Beta	n/a
RSI	37.12
Earnings Date	Apr 25, 2025

About Sinopharm Group

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 108,217
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: X2S

Financial Performance

In 2024, Sinopharm Group's revenue was 584.51 billion, a decrease of -2.02% compared to the previous year's 596.57 billion. Earnings were 7.05 billion, a decrease of -22.14%.

Financial numbers in CNY